We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 04. 30. | After market close (AMC) | $2.24 | — | — | $1.29B | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $1.51 | — | — | $1.19B | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $5.09 | — | — | $3.38B | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $3.77 | — | — | $2.23B | Reported |
Consensus PT $114.53 · 15 analysts
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 06. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2026. 05. 02. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
Compare a firm's past rating changes and its actions on other stocks in the same sector.